drugset / Trial / NCT04534270
Efficacy and Safety of Dapagliflozin in Children With Proteinuria
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to investigate the antiproteinuric effect of Dapagliflozin in children with proteinuria.
Timeline
- Start
- 2020-07-06
- Primary completion
- 2021-12-30
- Completion
- 2022-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 5 mg | — |
| Subject | Dapagliflozin | Small molecule | 10 mg | — |